1.10
-0.05(-4.35%)
Currency In USD
| Previous Close | 1.15 |
| Open | 1.15 |
| Day High | 1.19 |
| Day Low | 1.04 |
| 52-Week High | 12.02 |
| 52-Week Low | 1.04 |
| Volume | 499,776 |
| Average Volume | 735,577 |
| Market Cap | 118.92M |
| PE | -0.92 |
| EPS | -1.19 |
| Moving Average 50 Days | 1.59 |
| Moving Average 200 Days | 4.8 |
| Change | -0.05 |
If you invested $1000 in Tango Therapeutics, Inc. (TNGX) since IPO date, it would be worth $107.53 as of May 09, 2025 at a share price of $1.1. Whereas If you bought $1000 worth of Tango Therapeutics, Inc. (TNGX) shares 3 years ago, it would be worth $206.38 as of May 09, 2025 at a share price of $1.1.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
GlobeNewswire Inc.
May 01, 2025 11:00 AM GMT
BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report first quarter 2025 financial results on May 12, 2025, before the open of the U.S. financial markets. The company does not intend t
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire Inc.
Mar 25, 2025 8:30 PM GMT
BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that five abstract
Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences
GlobeNewswire Inc.
Feb 20, 2025 12:30 PM GMT
BOSTON, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Feb. 20, 2025-- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced tha